Craig-Hallum initiated coverage of Myriad Genetics (MYGN) with a Buy rating and $29 price target
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MYGN:
Education
About Us
Working with TipRanks
Follow Us
